US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Valneva SE

6.53

+0.07101.10%

Volume:51.03K

Turnover:333.62K

Market Cap:545.82M

PE:-37.53

High:6.56

Open:6.28

Low:6.25

Close:6.46

Loading ...

Overview Company News Filings

VALNEVA - Declaration of shares and voting rights: November 30, 2024

Valneva Highlights Chikungunya’s Global Economic Impact

Valneva Announces Peer-Reviewed Publication on the Global Health and Economic Burden of Chikungunya in The British Medical Journal

Valneva’s Chikungunya Vaccine Shows Long-Lasting Efficacy

Valneva Reports Positive Three-Year Antibody Persistence Data for its Single-Shot Chikungunya Vaccine IXCHIQ®

Chikungunya Vaccine Label Extension Call Likely to Support VALN Stock

Valneva Seeks FDA Approval for Expanded Vaccine Use

Valneva Submits Label Extension Application to US FDA for Chikungunya Vaccine IXCHIQ

MT Newswires Live

Valneva submits label extension application for chikungunya vaccine to FDA

Valneva Submits Label Extension Application for its Chikungunya Vaccine, IXCHIQ®, to the U.S. FDA

High Growth Tech Stocks To Explore This November 2024

Simply Wall St.

RFK Jr.'s Nomination to Head Health Department Will Shake Up Vaccine Landscape -- Market Talk

Vaccine Sector Sell-Off Looks Overdone -- Market Talk

European Vaccine Makers Under Pressure After Trump Picks RFK Jr to Lead Health Department

Valneva Engages Investors with Promising Vaccine Developments

Valneva and LimmaTech Announce First Vaccination in Phase 2b Human Challenge Study of Tetravalent Shigella Vaccine Candidate S4V2

Valneva to Present and Hold Investor Meetings at Upcoming U.S. and European Healthcare Conferences

Valneva SE (INRLF) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Improved ...

Valneva Narrows Its 2024 Guidance: Now Expects Total Revenues Of €170M-€180M (Prior €170M-€190M), And R&D Investments Between €65M-€75M

Valneva's Revenue For Nine Months €116.637M Up From €111.8M YoY; EPS €0.17 Up From €(0.50) YoY; Cash Position Of €156.335M

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/VALN/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"VALN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VALN\",,,,,undefined,":{"symbol":"VALN","market":"US","secType":"STK","nameCN":"Valneva SE","latestPrice":6.531,"timestamp":1746201231239,"preClose":6.46,"halted":0,"volume":51025,"delay":0,"floatShares":60632689,"shares":83573601,"eps":-0.174039,"marketStatus":"Trading","change":0.071,"latestTime":"05-02 11:56:03 EDT","open":6.28,"high":6.56,"low":6.25,"amount":333617.06365,"amplitude":0.047988,"askPrice":6.69,"askSize":2306,"bidPrice":6.29,"bidSize":569,"shortable":3,"etf":0,"ttmEps":-0.174039,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1746216000000},"marketStatusCode":2,"adr":0,"adrRate":2,"listingDate":1620273600000,"exchange":"NASDAQ","adjPreClose":6.46,"postHourTrading":{"tag":"盘后","latestPrice":6.38,"preClose":6.38,"latestTime":"16:00 EDT","volume":1,"amount":6.46,"timestamp":1746129621635},"volumeRatio":8.46734},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VALN\",,,,,undefined,":{"symbol":"VALN","floatShares":60632689,"roa":"-10.03%","roe":"-7.91%","lyrEps":-0.174039,"volumeRatio":8.46734,"shares":83573601,"dividePrice":0,"high":6.56,"amplitude":0.047988,"preClose":6.46,"low":6.25,"week52Low":3.62,"pbRate":"2.66","psRate":"2.84","week52High":9.5,"institutionHeld":0,"latestPrice":6.531,"committee":-0.604174,"eps":-0.174039,"divideRate":0,"volume":51025,"delay":0,"ttmEps":-0.174039,"open":6.28,"prevYearClose":4.372,"prevWeekClose":7.03,"prevMonthClose":6.345,"prevQuarterClose":6.71,"fiveDayClose":7.03,"twentyDayClose":6.97,"sixtyDayClose":6.67,"earningDate":1746547200000,"earningTime":"盘前"},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"VALN\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2489483766","title":"VALNEVA - Declaration of shares and voting rights: November 30, 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2489483766","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489483766?lang=en_us&edition=fundamental","pubTime":"2024-12-05 14:30","pubTimestamp":1733380200,"startTime":"0","endTime":"0","summary":"Company name: VALNEVARegistered office: 6 rue Alain Bombard, 44800 Saint-Herblain Regulated market of Euronext Paris - Compartment B. Number of shares composing the share capital of Valneva. Total number of voting rights including suspended voting rights*. Total number of voting rights excluding suspended voting rights**. 162,494,003 ordinary shares with a par value of 0.15 each. Transfer into bearer form of 1,000 shares with double voting rights  Double voting rights granted on 7,052 ordinary shares. * Theoretical voting rights. This number is used as the basis for calculating threshold crossings. In accordance with Article 223-11 of the AMF General Regulations, this number is calculated on the basis of all shares to which voting rights are attached, including those for which voting rights have been suspended.** Net  voting rights.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/dcoj_y6ZGAO7ZsNVSQf7nA--~B/aD0xNDA7dz05NjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/b71e6b080fbb9f52051d91fc548d0900","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/dcoj_y6ZGAO7ZsNVSQf7nA--~B/aD0xNDA7dz05NjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/b71e6b080fbb9f52051d91fc548d0900"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/valneva-declaration-shares-voting-rights-063000798.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["VALN","BK4139","BK4539","INRLF"],"gpt_icon":0},{"id":"2489935117","title":"Valneva Highlights Chikungunya’s Global Economic Impact","url":"https://stock-news.laohu8.com/highlight/detail?id=2489935117","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2489935117?lang=en_us&edition=fundamental","pubTime":"2024-12-05 01:28","pubTimestamp":1733333322,"startTime":"0","endTime":"0","summary":"Valneva (VALN) has released an update. Valneva SE has published a study in The British Medical Journal highlighting the severe health and economic ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/valneva-highlights-chikungunyas-global-economic-impact?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/valneva-highlights-chikungunyas-global-economic-impact?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","VALN","BK4139"],"gpt_icon":0},{"id":"2488139377","title":"Valneva Announces Peer-Reviewed Publication on the Global Health and Economic Burden of Chikungunya in The British Medical Journal","url":"https://stock-news.laohu8.com/highlight/detail?id=2488139377","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488139377?lang=en_us&edition=fundamental","pubTime":"2024-12-04 14:00","pubTimestamp":1733292000,"startTime":"0","endTime":"0","summary":"Saint-Herblain , December 4, 2024 – Valneva SE , a specialty vaccine company, today announces the publication of an article on the global health and economic burden of mosquito-borne disease chikungunya in The British Medical Journal , one of the world’s leading peer-reviewed medical journals.The article, titled, “The Global Health and Economic Burden of Chikungunya from 2011 to 2020: A Model-Driven Analysis on the Impact of an Emerging Vector-Borne Disease,” shows that chikungunya has a higher disease burden than was previously estimated, and costs related to the disease are substantial. According to the BMJ article, chikungunya could significantly impact local health systems due to its unpredictable and explosive nature.About Valneva SEWe are a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases addressing unmet medical needs. We take a highly specialized and targeted approach, applying our","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/dcoj_y6ZGAO7ZsNVSQf7nA--~B/aD0xNDA7dz05NjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/b71e6b080fbb9f52051d91fc548d0900","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/dcoj_y6ZGAO7ZsNVSQf7nA--~B/aD0xNDA7dz05NjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/b71e6b080fbb9f52051d91fc548d0900"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/valneva-announces-peer-reviewed-publication-060000854.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["VALN","INRLF","BK4139"],"gpt_icon":0},{"id":"2488914907","title":"Valneva’s Chikungunya Vaccine Shows Long-Lasting Efficacy","url":"https://stock-news.laohu8.com/highlight/detail?id=2488914907","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488914907?lang=en_us&edition=fundamental","pubTime":"2024-12-03 20:57","pubTimestamp":1733230651,"startTime":"0","endTime":"0","summary":"Valneva (VALN) has released an update. Valneva has announced promising three-year data for its single-dose chikungunya vaccine, IXCHIQ®, which main...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/valnevas-chikungunya-vaccine-shows-long-lasting-efficacy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/valnevas-chikungunya-vaccine-shows-long-lasting-efficacy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","VALN","BK4139"],"gpt_icon":0},{"id":"2488957243","title":"Valneva Reports Positive Three-Year Antibody Persistence Data for its Single-Shot Chikungunya Vaccine IXCHIQ®","url":"https://stock-news.laohu8.com/highlight/detail?id=2488957243","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488957243?lang=en_us&edition=fundamental","pubTime":"2024-12-03 14:00","pubTimestamp":1733205600,"startTime":"0","endTime":"0","summary":"Antibody levels remained high at 96% seroresponse in line with the two-year persistence data. This long-lasting antibody persistence was comparable in older (65+) and younger adults. Saint-Herblain , December 3, 2024 – Valneva SE , a specialty vaccine company, today reported positive antibody persistence data three years after vaccination with a single dose of its chikungunya vaccine IXCHIQ. The results are in line with Valneva’s expectations for this vaccine, confirming a strong and long-lasting antibody persistence across all age groups investigated. The three-year persistence data are also in line with positive twelve-month and two-year persistence data the Company reported in December 20221 and 20232, respectively.IXCHIQ is the world’s first and only licensed chikungunya vaccine available to address this significant unmet medical need. The vaccine is currently approved in the U.S.4, Europe5, and Canada6 for the prevention of disease caused by the chikungunya virus in individuals 18","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/dcoj_y6ZGAO7ZsNVSQf7nA--~B/aD0xNDA7dz05NjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/b71e6b080fbb9f52051d91fc548d0900","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/dcoj_y6ZGAO7ZsNVSQf7nA--~B/aD0xNDA7dz05NjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/b71e6b080fbb9f52051d91fc548d0900"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/valneva-reports-positive-three-antibody-060000515.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4156","VALN","INRLF","BK4179","CDC","AESI","BK4139"],"gpt_icon":0},{"id":"2487343949","title":"Chikungunya Vaccine Label Extension Call Likely to Support VALN Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2487343949","media":"Zacks","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2487343949?lang=en_us&edition=fundamental","pubTime":"2024-11-28 22:30","pubTimestamp":1732804200,"startTime":"0","endTime":"0","summary":"Valneva SE VALN recently applied for a label extension to the FDA to potentially extend the use of its chikungunya vaccine, IXCHIQ. Currently approved for adults, the vaccine may soon be accessible to adolescents aged 12 to 17 years, following the label extension.This submission is backed by positive adolescent Phase 3 data that demonstrated a 99.1% immune response rate and a favorable safety profile in adolescents. Expanding access to this age group addresses a critical gap, particularly as chikungunya continues to pose a growing threat globally.Subsequent to the news, the share price of VALN dropped 0.9% to $3.96 yesterday.Although the shares were southbound, the latest development is capable of generating positive market sentiment, considering the rising number of chikungunya cases in select geographies. We therefore expect market sentiment toward VALN stock to be positive surrounding this news.Valneva boasts a market capitalization of $321.8 million. The company is estimated to rep","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/B7EfA6ERTo_QO90H15uyXw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/B7EfA6ERTo_QO90H15uyXw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/chikungunya-vaccine-label-extension-call-143000377.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00B64QTZ34.USD","BK4539","BK4082","LU1169590202.USD","LU1169589451.USD","LU2065732104.USD","IE00BLDYK493.USD","BK4139","PEN","IE0009354923.USD","BK4198","INRLF","LU0205193047.USD","GMED","LU0205194284.USD","VALN","HAE","LU0012050646.USD","LU0106261612.USD","BK4548"],"gpt_icon":0},{"id":"2486853483","title":"Valneva Seeks FDA Approval for Expanded Vaccine Use","url":"https://stock-news.laohu8.com/highlight/detail?id=2486853483","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486853483?lang=en_us&edition=fundamental","pubTime":"2024-11-27 06:31","pubTimestamp":1732660269,"startTime":"0","endTime":"0","summary":"Valneva (VALN) has released an update. Valneva has submitted an application to the U.S. FDA to extend the use of its chikungunya vaccine, IXCHIQ®, ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/valneva-seeks-fda-approval-for-expanded-vaccine-use?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/valneva-seeks-fda-approval-for-expanded-vaccine-use?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VALN","BK4539","BK4139"],"gpt_icon":0},{"id":"2486488977","title":"Valneva Submits Label Extension Application to US FDA for Chikungunya Vaccine IXCHIQ","url":"https://stock-news.laohu8.com/highlight/detail?id=2486488977","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486488977?lang=en_us&edition=fundamental","pubTime":"2024-11-27 01:27","pubTimestamp":1732642021,"startTime":"0","endTime":"0","summary":"Valneva  said Tuesday it has submitted a label extension application to the US Food and Drug Administration to expand the use of its chikungunya virus vaccine IXCHIQ to individuals between 12 and 17 years old.The application also seeks to include two-year antibody persistence data on the product label, highlighting a key differentiator for IXCHIQ, which is currently approved for use in adults, the vaccine maker said.The label extension application is based on positive phase 3 data from May, showing that a single dose of IXCHIQ produced a \"high\" and \"sustained\" immune response in 99.1% of adolescents, with the vaccine being generally well tolerated, Valneva said.Shares of Valneva were down nearly 6% in recent Tuesday trading.Price: 4.08, Change: -0.25, Percent Change: -5.77","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4539","VALN","BK4139"],"gpt_icon":0},{"id":"2486886663","title":"Valneva submits label extension application for chikungunya vaccine to FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2486886663","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486886663?lang=en_us&edition=fundamental","pubTime":"2024-11-27 00:50","pubTimestamp":1732639809,"startTime":"0","endTime":"0","summary":"Valneva (VALN) announced that it has submitted a label extension application to the U.S. Food and Drug Administration to potentially extend the use...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/valneva-submits-label-extension-application-for-chikungunya-vaccine-to-fda?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/valneva-submits-label-extension-application-for-chikungunya-vaccine-to-fda?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4539","VALN"],"gpt_icon":0},{"id":"2486886284","title":"Valneva Submits Label Extension Application for its Chikungunya Vaccine, IXCHIQ®, to the U.S. FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2486886284","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486886284?lang=en_us&edition=fundamental","pubTime":"2024-11-27 00:45","pubTimestamp":1732639500,"startTime":"0","endTime":"0","summary":"To potentially include adolescents and antibody persistence up to two years. Saint Herblain , November 26, 2024 – Valneva SE , a specialty vaccine company, today announced that it has submitted a label extension application to the U.S. Food and Drug Administration  to potentially extend the use of its chikungunya vaccine IXCHIQ, which is currently approved in adults, to adolescents aged 12 to 17 years. The application also includes adding the two-year antibody persistence data to the product label, which is a key differentiator for IXCHIQ. This FDA application follows the submission of label extension applications to the European Medicines Agency  and Health Canada two months ago1.IXCHIQ is the world’s first and only licensed chikungunya vaccine available to address this significant unmet medical need. The vaccine is currently approved in the U.S.4, Europe5, and Canada6 for the prevention of disease caused by the chikungunya virus in individuals 18 years of age and older. It was launch","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/dcoj_y6ZGAO7ZsNVSQf7nA--~B/aD0xNDA7dz05NjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/b71e6b080fbb9f52051d91fc548d0900","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/dcoj_y6ZGAO7ZsNVSQf7nA--~B/aD0xNDA7dz05NjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/b71e6b080fbb9f52051d91fc548d0900"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/valneva-submits-label-extension-application-164500144.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4539","CDC","VALN","BK4139","BK4156","INRLF"],"gpt_icon":0},{"id":"2486972063","title":"High Growth Tech Stocks To Explore This November 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2486972063","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2486972063?lang=en_us&edition=fundamental","pubTime":"2024-11-25 14:09","pubTimestamp":1732514980,"startTime":"0","endTime":"0","summary":"As global markets experience broad-based gains with smaller-cap indexes outperforming large-caps, investors are closely watching the Federal Reserve's upcoming decisions on interest rates amid a strong U.S. labor market and rising home sales. In this environment, identifying high growth tech stocks involves focusing on companies that can capitalize on technological advancements and maintain robust performance despite geopolitical tensions and economic uncertainties.Click here to see the full list of 1300 stocks from our High Growth Tech and AI Stocks screener.We're going to check out a few of the best picks from our screener tool.ENXTPA:VLA Revenue and Expenses Breakdown as at Nov 2024. Operations: The company generates revenue primarily through its Publishing a","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/d3vISzLZXw94x30FKv9beA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/d3vISzLZXw94x30FKv9beA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4d522452d0da08d8412701a84270533b"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/high-growth-tech-stocks-explore-060940750.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BTRCF","BK4077","VALN","STRYF","INRLF"],"gpt_icon":0},{"id":"2483329582","title":"RFK Jr.'s Nomination to Head Health Department Will Shake Up Vaccine Landscape -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2483329582","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483329582?lang=en_us&edition=fundamental","pubTime":"2024-11-15 19:22","pubTimestamp":1731669720,"startTime":"0","endTime":"0","summary":"1122 GMT - Robert F. Kennedy Jr.'s nomination as Health and Human Services secretary will likely impact vaccine makers and the Food and Drug Administration, Jefferies analysts write. Kennedy has publicly criticized childhood and mRNA-based vaccines, the analysts say. Vaccine perception in the U.S. could suffer, leading to lower demand and sales and potentially cause outbreaks if vaccinations are not consistent over the next four years, Jefferies says. Kennedy has also been vocal on overhauling the FDA, which could alter the regulatory path, resources for biotech and drug review positions as well as impacting key FDA leadership. Bavarian Nordic shares are down 16%, with Valneva down 6%. ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"8b50228a679c44f870e44bbf889089f6","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VALN","BK4539"],"gpt_icon":0},{"id":"2483078328","title":"Vaccine Sector Sell-Off Looks Overdone -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2483078328","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483078328?lang=en_us&edition=fundamental","pubTime":"2024-11-15 18:34","pubTimestamp":1731666840,"startTime":"0","endTime":"0","summary":"1033 GMT - The vaccine sector is under pressure after the nomination of Robert F. Kennedy Jr. as U.S.'s Health Secretary, but the market reaction looks overdone, Bryan Garnier Research analysts write. Kennedy is feared for his anti-vax positions, the analysts say. Shares in Pfizer, GSK, Moderna and BioNTech all dropped in Thursday's U.S. session and the sell-off has continued in Europe. Bavarian Nordic shares are down 16%, Valneva shares 6.1% lower with GSK and Sanofi both down 2.7%. However, the analysts believe the vaccine recommendation process has rigid structures in place, and U.S. governmental action will likely focus more on increased transparency and public information on vaccine risks and benefits. \"We thus expect no impact on Valneva and Bavarian Nordic business near-term.\" ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSK.UK","LU0456855351.SGD","BK4534","MRNA","BK4532","GSK","BK4581","BK4592","BK4539","LU0234572021.USD","LU1057294990.SGD","BK4585","BNTX","PFE","BK4533","IE00BLSP4239.USD","SG9999013999.USD","IE00BFXG1179.USD","LU1829250122.USD","BK4139","BK4548","VALN","LU1066051498.USD","IE00B19Z3B42.SGD","IE00BBT3K403.USD","LU0225284248.USD","LU0321505868.SGD","SG9999011175.SGD","LU0225771236.USD","IE0002270589.USD","LU1894683264.USD","LU1023059063.AUD","BK4007","IE00B19Z3581.USD","SNY","BK4535","IE000M9KFDE8.USD","LU0306806265.USD","LU1066053197.SGD","SG9999003800.SGD","SG9999001176.SGD","LU0289739699.SGD","LU0868494617.USD","SG9999001176.USD","SGXZ57979304.SGD","LU0321505439.SGD","SG9999002224.SGD","LU0985481810.HKD","LU0170899867.USD","BK4550"],"gpt_icon":1},{"id":"2483582340","title":"European Vaccine Makers Under Pressure After Trump Picks RFK Jr to Lead Health Department","url":"https://stock-news.laohu8.com/highlight/detail?id=2483582340","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483582340?lang=en_us&edition=fundamental","pubTime":"2024-11-15 18:13","pubTimestamp":1731665580,"startTime":"0","endTime":"0","summary":"Shares in European vaccine makers tumbled Friday after President-elect Donald Trump picked vaccine sceptic Robert F. Kennedy Jr. to lead the Department of Health and Human Services.In early European trade, Bavarian Nordic shares fell as much as 19%, while Valneva shares dropped as much as 10%. GSK and Sanofi both fell around 4%.Kennedy has been a vocal critic of public-health leaders' approaches to the Covid-19 pandemic and vaccines in recent years. He has also claimed that unhealthy food, medicines and water have fueled the rise of chronic disease in America, and that government regulators have been corrupted by corporate influence.RFK Jr has promised sweeping changes to food-and-drug regulation and government-funded scientific research, but said he wouldn't \"take away\" anybody's vaccines.He is particularly critical of childhood mandated vaccines, which he claims are exempt from prelicensing safety trials. He previously claimed vaccines increase the risk of autism in children.Trump sa","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"8b50228a679c44f870e44bbf889089f6","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","BK4548","BK4588","BK4568","BK4532","BNTX","BK4535","BK4551","MRNA","BK4139","BK4585","BK4501","BK4533","IE00BFXG1179.USD","LU1829250122.USD","PFE","SNY","GSK.UK","GSK","BK4007","VALN","BK4539"],"gpt_icon":1},{"id":"2483885109","title":"Valneva Engages Investors with Promising Vaccine Developments","url":"https://stock-news.laohu8.com/highlight/detail?id=2483885109","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483885109?lang=en_us&edition=fundamental","pubTime":"2024-11-14 03:49","pubTimestamp":1731527393,"startTime":"0","endTime":"0","summary":"Valneva (VALN) has released an update. Valneva is set to engage with institutional investors at major U.S. and European healthcare conferences, whe...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/valneva-engages-investors-with-promising-vaccine-developments?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/valneva-engages-investors-with-promising-vaccine-developments?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ISBC","BK4139","BK4211","BK4539","VALN"],"gpt_icon":0},{"id":"2483883101","title":"Valneva and LimmaTech Announce First Vaccination in Phase 2b Human Challenge Study of Tetravalent Shigella Vaccine Candidate S4V2","url":"https://stock-news.laohu8.com/highlight/detail?id=2483883101","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483883101?lang=en_us&edition=fundamental","pubTime":"2024-11-14 00:45","pubTimestamp":1731516300,"startTime":"0","endTime":"0","summary":"Saint Herblain  and Schlieren , November 13, 2024 – Valneva SE , a specialty vaccine company, and LimmaTech Biologics AG, a clinical-stage biotech company developing vaccines for the prevention of life-threatening diseases, announced today that the first participant has been vaccinated in a Phase 2b controlled human infection model  study of Shigella4V2 , the world’s most clinically advanced tetravalent bioconjugate shigellosis vaccine candidate, for which Valneva obtained an exclusive worldwide license from LimmaTech1.Thomas Lingelbach, Chief Executive Officer of Valneva, commented, “Human challenge studies are unique in their ability to investigate and understand the onset and development of disease in a safe and highly controlled environment. This CHIM study forms part of our staggered and risk-mitigating development strategy for S4V2, as it should provide the first results on efficacy before potentially advancing to further CHIM and Phase 3 studies.”Shigellosis is the second leadin","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/dcoj_y6ZGAO7ZsNVSQf7nA--~B/aD0xNDA7dz05NjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/b71e6b080fbb9f52051d91fc548d0900","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/dcoj_y6ZGAO7ZsNVSQf7nA--~B/aD0xNDA7dz05NjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/b71e6b080fbb9f52051d91fc548d0900"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/valneva-limmatech-announce-first-vaccination-164500880.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","VALN","INRLF","CHIM"],"gpt_icon":0},{"id":"2482741607","title":"Valneva to Present and Hold Investor Meetings at Upcoming U.S. and European Healthcare Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2482741607","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482741607?lang=en_us&edition=fundamental","pubTime":"2024-11-12 14:00","pubTimestamp":1731391200,"startTime":"0","endTime":"0","summary":"Saint-Herblain , November 12, 2024 – Valneva SE , a specialty vaccine company, today announced that its senior management will present and participate in 1-on-1 meetings with institutional investors at upcoming investor conferences in the United States and Europe.Chief Executive Officer Thomas Lingelbach and Chief Financial Officer Peter Bühler will host moderated “fireside chat” presentations to discuss the Company’s key value drivers and upcoming catalysts, which include multiple clinical data events in 2025, most notably key Phase 3 conclusions for VLA15, the Company’s Lyme disease vaccine candidate, which is partnered with Pfizer. If successful, Pfizer aims to submit applications for U.S. and European market authorization in 2026.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/dcoj_y6ZGAO7ZsNVSQf7nA--~B/aD0xNDA7dz05NjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/b71e6b080fbb9f52051d91fc548d0900","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/dcoj_y6ZGAO7ZsNVSQf7nA--~B/aD0xNDA7dz05NjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/b71e6b080fbb9f52051d91fc548d0900"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/valneva-present-hold-investor-meetings-060000867.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4550","LU0321505868.SGD","LU0225284248.USD","LU1023059063.AUD","IE000M9KFDE8.USD","LU1066053197.SGD","IE00BLSP4452.SGD","LU0225771236.USD","BK4534","SG9999003800.SGD","IE0002270589.USD","SG9999013999.USD","LU0122379950.USD","BK4581","BK4585","IE00BLSP4239.USD","LU0306807586.USD","LU1894683264.USD","LU0234572021.USD","SG9999002232.USD","LU0058720904.USD","LU0289739699.SGD","SG9999011175.SGD","IE00B19Z3B42.SGD","LU1894683348.USD","HCSG","BK4588","BK4007","BK4568","SGXZ57979304.SGD","PFE","SG9999001176.USD","INRLF","IE00B19Z3581.USD","BK4592","LU0321505439.SGD","LU1066051498.USD","BK4139","LU0306806265.USD","SG9999002224.SGD","LU0868494617.USD","LU0985481810.HKD","LU1883839398.USD","SG9999001176.SGD","VALN","BK4137","LU0170899867.USD","LU1057294990.SGD","LU0456855351.SGD","BK4533","BK4539"],"gpt_icon":1},{"id":"2481146359","title":"Valneva SE (INRLF) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Improved ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2481146359","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481146359?lang=en_us&edition=fundamental","pubTime":"2024-11-08 15:17","pubTimestamp":1731050273,"startTime":"0","endTime":"0","summary":"Product Sales: EUR112.5 million, a 12% increase over the prior year.Total Revenue: EUR116.6 million, up from EUR111.8 million in the first nine months of 2023.IXIARO Gross Margin: 58.8% compared to 47.2% one year ago.DUKORAL Sales: EUR22.3 million, a 6% increase year over year.Chikungunya Vaccine Sales: EUR1.8 million in the United States by September 30th.Operating Profit: EUR34.2 million versus an operating loss of minus EUR57.2 million in the prior year.Adjusted EBITDA: Improved from minus EUR46 million to positive EUR48.6 million.Cash Position: EUR156.3 million as of September 30th.R&D Expense: Increased to EUR48.6 million from EUR42.2 million in the prior year.Marketing and Distribution Expense: Increased by 5% to EUR35.7 million.General and Administrative Expense: Decreased by 7% to EUR32.6 million.Cash Use in Operating Activities: Decreased from EUR136 million to EUR76.7 million.Guidance for Total Revenue: EUR170 to EUR180 million for the current fiscal year.GuruFocus has detect","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/MYtM.96.O_SqSnC78H4t0w--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/f8494d5ab324599714fb763477a28d74","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/MYtM.96.O_SqSnC78H4t0w--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/us.finance.gurufocus/f8494d5ab324599714fb763477a28d74"],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/valneva-se-inrlf-q3-2024-071753544.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["INRLF","VALN"],"gpt_icon":0},{"id":"2481493949","title":"Valneva Narrows Its 2024 Guidance: Now Expects Total Revenues Of €170M-€180M (Prior €170M-€190M), And R&D Investments Between €65M-€75M","url":"https://stock-news.laohu8.com/highlight/detail?id=2481493949","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481493949?lang=en_us&edition=fundamental","pubTime":"2024-11-07 14:30","pubTimestamp":1730961024,"startTime":"0","endTime":"0","summary":"Full-year 2024 Financial Guidance NarrowedExpected total product sales according to guidance between €160 million to €170 million and currently anticipated total revenues between €170 million and €180","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/11/41797102/valneva-narrows-its-2024-guidance-now-expects-total-revenues-of-170m-180m-prior-170m-190m-and-r-d-i","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VALN","TSS"],"gpt_icon":0},{"id":"2481463649","title":"Valneva's Revenue For Nine Months €116.637M Up From €111.8M YoY; EPS €0.17 Up From €(0.50) YoY; Cash Position Of €156.335M","url":"https://stock-news.laohu8.com/highlight/detail?id=2481463649","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481463649?lang=en_us&edition=fundamental","pubTime":"2024-11-07 14:10","pubTimestamp":1730959838,"startTime":"0","endTime":"0","summary":"Valneva's Revenue For Nine Months €116.637M Up From €111.8M YoY; EPS €0.17 Up From €(0.50) YoY; Cash Position Of €156.335M","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/11/41796938/valnevas-revenue-for-nine-months-116-637m-up-from-111-8m-yoy-eps-0-17-up-from-0-50-yoy-cash-positio","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Valneva's Revenue For Nine Months €116.637M Up From €111.8M YoY; EPS €0.17 Up From €(0.50) YoY; Cash Position Of €156.335M","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VALN"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":4,"totalSize":83,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/VALN\",params:#limit:5,,,undefined,":[{"date":"2025-05-07","symbol":"VALN","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2025/03","expectedEps":-0.31,"defaultRemindTime":1746604800000,"name":null,"time":"Pre-Market","dateTimestamp":1746590400000,"actualEps":null},{"market":"US","date":"2025-03-20","symbol":"VALN","fiscalQuarterEnding":"2024/12","expectedEps":-0.22,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1742443200000,"reportTimeType":"pre","actualEps":-0.54},{"market":"US","date":"2024-11-07","symbol":"VALN","fiscalQuarterEnding":"2024/09","expectedEps":-0.3,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"pre","actualEps":-0.15},{"market":"US","date":"2024-08-13","symbol":"VALN","fiscalQuarterEnding":"2024/06","expectedEps":-0.39,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723521600000,"reportTimeType":"pre","actualEps":-0.37},{"market":"US","date":"2024-05-07","symbol":"VALN","fiscalQuarterEnding":"2024/03","expectedEps":0.77,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715054400000,"reportTimeType":"pre","actualEps":0.89}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"VALN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"VALN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.25,"hold":0.25,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.25,"analysts":4,"updateTime":1668225600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/VALN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"VALN","date":"2025-05-01","current":-39.442754,"percent":0.166396,"low":-218.184634,"twenty":-23.549255,"median":-13.439745,"eighty":-5.807116,"high":13.644639,"avg":-19.636053,"sd":25.408318,"marketCap":544717425.58},"quantilePoints":[{"date":"2020-05-08","current":-45.383648,"twenty":-43.681489,"median":-25.42373,"eighty":-4.691885,"marketCap":385512246.83},{"date":"2020-05-15","current":-44.324108,"twenty":-43.812284,"median":-25.440934,"eighty":-4.691885,"marketCap":375411764.07},{"date":"2020-05-22","current":-44.618425,"twenty":-43.817691,"median":-25.546607,"eighty":-4.708823,"marketCap":380374502.18},{"date":"2020-05-29","current":-44.265245,"twenty":-43.878266,"median":-25.588418,"eighty":-4.708823,"marketCap":385124852.7},{"date":"2020-06-05","current":-44.561073,"twenty":-43.948952,"median":-25.609238,"eighty":-4.708823,"marketCap":394675142.6},{"date":"2020-06-12","current":-45.620649,"twenty":-44.085703,"median":-25.643724,"eighty":-4.708823,"marketCap":401199236.99},{"date":"2020-06-19","current":-53.508607,"twenty":-44.205807,"median":-25.710593,"eighty":-4.722373,"marketCap":468776845.4},{"date":"2020-06-26","current":-51.56605,"twenty":-44.265245,"median":-25.791207,"eighty":-4.725761,"marketCap":452366222.4},{"date":"2020-07-02","current":-55.74549,"twenty":-44.292711,"median":-25.845734,"eighty":-4.725761,"marketCap":490460040.47},{"date":"2020-07-10","current":-49.741224,"twenty":-44.402723,"median":-25.957127,"eighty":-4.735924,"marketCap":440405949.77},{"date":"2020-07-17","current":-52.095838,"twenty":-44.500967,"median":-26.178353,"eighty":-4.742699,"marketCap":465945177.14},{"date":"2020-07-24","current":-57.158259,"twenty":-44.576376,"median":-26.252094,"eighty":-4.742699,"marketCap":520261144.45},{"date":"2020-07-31","current":-55.510029,"twenty":-44.599331,"median":-26.325836,"eighty":-4.752862,"marketCap":513925807.41},{"date":"2020-08-07","current":-20.100131,"twenty":-44.599331,"median":-26.252094,"eighty":-4.759638,"marketCap":591868791.84},{"date":"2020-08-14","current":-19.583798,"twenty":-44.599331,"median":-26.18097,"eighty":-4.769801,"marketCap":578848125.89},{"date":"2020-08-21","current":-20.579584,"twenty":-44.599331,"median":-26.149802,"eighty":-4.776576,"marketCap":605629838.61},{"date":"2020-08-28","current":-19.436274,"twenty":-44.599331,"median":-25.899888,"eighty":-4.776576,"marketCap":577562738.19},{"date":"2020-09-04","current":-17.38938,"twenty":-44.576376,"median":-25.809643,"eighty":-4.776576,"marketCap":512410338.52},{"date":"2020-09-11","current":-18.809297,"twenty":-44.560468,"median":-25.735902,"eighty":-4.783351,"marketCap":556219063.68},{"date":"2020-09-18","current":-24.267682,"twenty":-44.549389,"median":-25.669484,"eighty":-4.793514,"marketCap":719249284.61},{"date":"2020-09-25","current":-25.484754,"twenty":-44.521026,"median":-25.609238,"eighty":-4.793514,"marketCap":739700382.25},{"date":"2020-10-02","current":-25.263468,"twenty":-44.501102,"median":-25.617263,"eighty":-4.800289,"marketCap":739290097.22},{"date":"2020-10-09","current":-24.710253,"twenty":-44.487836,"median":-25.588418,"eighty":-4.810452,"marketCap":729424019.85},{"date":"2020-10-16","current":-25.152825,"twenty":-44.468388,"median":-25.573467,"eighty":-4.810452,"marketCap":736138559.04},{"date":"2020-10-23","current":-23.161252,"twenty":-44.442076,"median":-25.541667,"eighty":-4.817228,"marketCap":684912885.89},{"date":"2020-10-30","current":-22.460514,"twenty":-44.402801,"median":-25.444403,"eighty":-4.827391,"marketCap":653896464.28},{"date":"2020-11-06","current":-8.555896,"twenty":-44.376488,"median":-25.440934,"eighty":-4.827391,"marketCap":626984846.65},{"date":"2020-11-13","current":-8.201859,"twenty":-44.337213,"median":-25.405295,"eighty":-4.827391,"marketCap":597913187.09},{"date":"2020-11-20","current":-8.260865,"twenty":-44.331832,"median":-25.30517,"eighty":-4.827391,"marketCap":603928804.55},{"date":"2020-11-27","current":-9.160709,"twenty":-44.313642,"median":-25.263468,"eighty":-4.827391,"marketCap":675158735.05},{"date":"2020-12-04","current":-9.384421,"twenty":-44.271779,"median":-25.238145,"eighty":-4.830779,"marketCap":702054944.17},{"date":"2020-12-11","current":-10.166457,"twenty":-44.270472,"median":-25.145967,"eighty":-4.844329,"marketCap":759085570.49},{"date":"2020-12-18","current":-12.394519,"twenty":-44.265245,"median":-24.864965,"eighty":-4.844329,"marketCap":934386351.96},{"date":"2020-12-24","current":-11.302621,"twenty":-44.265245,"median":-24.780636,"eighty":-4.844329,"marketCap":849060143.8},{"date":"2020-12-31","current":-11.435419,"twenty":-44.218002,"median":-24.720537,"eighty":-4.844329,"marketCap":862293553.52},{"date":"2021-01-08","current":-11.082813,"twenty":-44.206191,"median":-24.528109,"eighty":-4.844329,"marketCap":836626157.24},{"date":"2021-01-15","current":-14.609833,"twenty":-44.205884,"median":-24.488967,"eighty":-4.857879,"marketCap":1088875061.06},{"date":"2021-01-22","current":-13.399726,"twenty":-44.205807,"median":-24.419432,"eighty":-4.861267,"marketCap":1005493246.5},{"date":"2021-01-29","current":-13.990022,"twenty":-44.205807,"median":-24.291612,"eighty":-4.861267,"marketCap":1046857158.29},{"date":"2021-02-05","current":-21.168008,"twenty":-44.166685,"median":-24.188992,"eighty":-4.861267,"marketCap":1569686869.96},{"date":"2021-02-12","current":-19.590083,"twenty":-44.133314,"median":-24.083277,"eighty":-4.861267,"marketCap":1463593633.5},{"date":"2021-02-19","current":-18.280108,"twenty":-44.107079,"median":-24.055115,"eighty":-4.868042,"marketCap":1367215478.04},{"date":"2021-02-26","current":-15.789643,"twenty":-44.075015,"median":-23.953759,"eighty":-4.878205,"marketCap":1230178441.62},{"date":"2021-03-05","current":-14.535592,"twenty":-44.046669,"median":-23.861991,"eighty":-4.878205,"marketCap":1115070731.47},{"date":"2021-03-12","current":-14.450088,"twenty":-43.990861,"median":-23.852403,"eighty":-4.878205,"marketCap":1111291706.68},{"date":"2021-03-19","current":-14.421587,"twenty":-43.95994,"median":-23.67113,"eighty":-4.878205,"marketCap":1105271686.5},{"date":"2021-03-26","current":-14.649597,"twenty":-43.943458,"median":-23.55764,"eighty":-4.878205,"marketCap":1112550386.84},{"date":"2021-04-01","current":-15.248121,"twenty":-43.930735,"median":-23.416221,"eighty":-4.878205,"marketCap":1155279742.32},{"date":"2021-04-09","current":-17.499713,"twenty":-43.879449,"median":-23.302421,"eighty":-4.878205,"marketCap":1339107542.48},{"date":"2021-04-16","current":-17.955731,"twenty":-43.877871,"median":-23.179693,"eighty":-4.878205,"marketCap":1385030427.65},{"date":"2021-04-23","current":-16.331165,"twenty":-43.865835,"median":-22.976847,"eighty":-4.881593,"marketCap":1268378617.78},{"date":"2021-04-30","current":-19.965063,"twenty":-43.816686,"median":-22.77089,"eighty":-4.895143,"marketCap":1546505840.25},{"date":"2021-05-07","current":-18.896475,"twenty":-43.812664,"median":-22.180262,"eighty":-4.895143,"marketCap":1478853561.01},{"date":"2021-05-14","current":-18.521699,"twenty":-43.812588,"median":-21.978065,"eighty":-4.895143,"marketCap":1447588034.96},{"date":"2021-05-21","current":-12.751807,"twenty":-43.812284,"median":-21.796656,"eighty":-4.895143,"marketCap":1412194659.35},{"date":"2021-05-28","current":-11.652514,"twenty":-43.812284,"median":-21.556929,"eighty":-4.895143,"marketCap":1290453740.4},{"date":"2021-06-04","current":-12.400033,"twenty":-43.812284,"median":-21.313441,"eighty":-4.895143,"marketCap":1370898432.9},{"date":"2021-06-11","current":-12.751807,"twenty":-43.755538,"median":-21.090166,"eighty":-4.895143,"marketCap":1401603626.47},{"date":"2021-06-18","current":-12.334076,"twenty":-43.746697,"median":-20.856192,"eighty":-4.912082,"marketCap":1328687749.85},{"date":"2021-06-25","current":-11.828401,"twenty":-43.736958,"median":-20.468941,"eighty":-4.912082,"marketCap":1283649160.4},{"date":"2021-07-02","current":-12.630885,"twenty":-43.681489,"median":-20.339858,"eighty":-4.912082,"marketCap":1359211263.62},{"date":"2021-07-09","current":-12.564927,"twenty":-43.629019,"median":-20.118572,"eighty":-4.912082,"marketCap":1354519736.62},{"date":"2021-07-16","current":-12.136203,"twenty":-43.615901,"median":-19.965063,"eighty":-4.912082,"marketCap":1302123273.11},{"date":"2021-07-23","current":-13.026631,"twenty":-43.615598,"median":-19.666514,"eighty":-4.912082,"marketCap":1392398334.31},{"date":"2021-07-30","current":-13.037624,"twenty":-43.601125,"median":-19.583798,"eighty":-4.912082,"marketCap":1405310448.4},{"date":"2021-08-06","current":-13.466348,"twenty":-43.574769,"median":-19.537399,"eighty":-4.912082,"marketCap":1439399122.46},{"date":"2021-08-13","current":-9.031199,"twenty":-43.554066,"median":-19.436274,"eighty":-4.912082,"marketCap":1333823072.93},{"date":"2021-08-20","current":-9.772507,"twenty":-43.550313,"median":-19.355826,"eighty":-4.912082,"marketCap":1428806710.28},{"date":"2021-08-27","current":-13.032666,"twenty":-43.545653,"median":-19.251869,"eighty":-4.912082,"marketCap":1923213368.71},{"date":"2021-09-03","current":-16.138703,"twenty":-43.496678,"median":-19.050185,"eighty":-4.912082,"marketCap":2400246131.91},{"date":"2021-09-10","current":-15.902522,"twenty":-43.460755,"median":-18.930671,"eighty":-4.912082,"marketCap":2354209006.39},{"date":"2021-09-17","current":-9.244538,"twenty":-43.429392,"median":-18.831946,"eighty":-4.912082,"marketCap":1358119132.53},{"date":"2021-09-24","current":-10.520018,"twenty":-43.418911,"median":-18.702304,"eighty":-4.912082,"marketCap":1541700003.51},{"date":"2021-10-01","current":-10.152855,"twenty":-43.398728,"median":-18.607602,"eighty":-4.912082,"marketCap":1473058489.45},{"date":"2021-10-08","current":-9.96089,"twenty":-43.383722,"median":-18.45965,"eighty":-4.912082,"marketCap":1442697950.47},{"date":"2021-10-15","current":-9.577779,"twenty":-43.325826,"median":-18.335552,"eighty":-4.922245,"marketCap":1390589081.21},{"date":"2021-10-22","current":-15.164817,"twenty":-43.287962,"median":-18.226492,"eighty":-4.92902,"marketCap":2207656544.14},{"date":"2021-10-29","current":-16.056507,"twenty":-43.25094,"median":-18.034797,"eighty":-4.92902,"marketCap":2323681768.04},{"date":"2021-11-05","current":-14.859108,"twenty":-43.184575,"median":-17.958959,"eighty":-4.92902,"marketCap":2148904537.79},{"date":"2021-11-12","current":-17.427971,"twenty":-43.156786,"median":-17.955731,"eighty":-4.92902,"marketCap":2497038206.07},{"date":"2021-11-19","current":-18.049199,"twenty":-43.150819,"median":-17.954173,"eighty":-4.92902,"marketCap":2557354752.63},{"date":"2021-11-26","current":-21.826939,"twenty":-43.141709,"median":-17.954173,"eighty":-4.92902,"marketCap":3091215201.99},{"date":"2021-12-03","current":-19.828934,"twenty":-43.128479,"median":-18.012734,"eighty":-4.92902,"marketCap":2801276249.01},{"date":"2021-12-10","current":-19.190916,"twenty":-43.082353,"median":-18.045217,"eighty":-4.92902,"marketCap":2717276542.6},{"date":"2021-12-17","current":-21.6952,"twenty":-43.02561,"median":-18.049199,"eighty":-4.92902,"marketCap":3061471834.48},{"date":"2021-12-23","current":-21.258609,"twenty":-43.012701,"median":-18.133149,"eighty":-4.92902,"marketCap":3010726187.62},{"date":"2021-12-31","current":-20.570139,"twenty":-42.961066,"median":-18.260425,"eighty":-4.92902,"marketCap":2927800125.1},{"date":"2022-01-07","current":-14.759057,"twenty":-42.960783,"median":-18.212242,"eighty":-4.932408,"marketCap":2094738393.06},{"date":"2022-01-14","current":-13.750466,"twenty":-42.95965,"median":-18.065989,"eighty":-4.945958,"marketCap":1965633407.2},{"date":"2022-01-21","current":-13.162121,"twenty":-42.95965,"median":-18.049199,"eighty":-4.945958,"marketCap":1868298618.58},{"date":"2022-01-28","current":-12.472916,"twenty":-42.947553,"median":-18.034797,"eighty":-4.945958,"marketCap":1742407533.21},{"date":"2022-02-04","current":-12.507426,"twenty":-42.854989,"median":-17.958959,"eighty":-4.945958,"marketCap":1791213902.05},{"date":"2022-02-11","current":-13.132369,"twenty":-42.833778,"median":-17.931531,"eighty":-4.945958,"marketCap":1874492871.81},{"date":"2022-02-18","current":-12.610156,"twenty":-42.833778,"median":-17.931531,"eighty":-4.945958,"marketCap":1788529970.53},{"date":"2022-02-25","current":-12.841299,"twenty":-42.833778,"median":-17.931531,"eighty":-4.945958,"marketCap":1810643459.89},{"date":"2022-03-04","current":-11.805779,"twenty":-42.833778,"median":-17.931531,"eighty":-4.945958,"marketCap":1612670420.21},{"date":"2022-03-11","current":-13.338219,"twenty":-42.833778,"median":-17.931531,"eighty":-4.945958,"marketCap":1827587115.17},{"date":"2022-03-18","current":-14.922025,"twenty":-42.833778,"median":-17.931531,"eighty":-4.945958,"marketCap":2065858627.21},{"date":"2022-03-25","current":-22.866341,"twenty":-42.833778,"median":-17.958959,"eighty":-4.945958,"marketCap":1844809487.97},{"date":"2022-04-01","current":-23.676221,"twenty":-42.833778,"median":-18.049199,"eighty":-4.945958,"marketCap":1918793105.96},{"date":"2022-04-08","current":-23.215059,"twenty":-42.833778,"median":-18.226492,"eighty":-4.945958,"marketCap":1853997954.1},{"date":"2022-04-14","current":-24.609577,"twenty":-42.833778,"median":-18.416116,"eighty":-4.945958,"marketCap":1952834996.22},{"date":"2022-04-22","current":-22.620554,"twenty":-42.833778,"median":-18.616247,"eighty":-4.945958,"marketCap":1790356988.25},{"date":"2022-04-29","current":-18.158096,"twenty":-42.833778,"median":-18.660826,"eighty":-4.945958,"marketCap":1405056559.17},{"date":"2022-05-06","current":-18.195389,"twenty":-42.833778,"median":-18.660826,"eighty":-4.945958,"marketCap":1383381571.14},{"date":"2022-05-13","current":-17.91003,"twenty":-42.833778,"median":-18.660826,"eighty":-4.945958,"marketCap":1337873805.56},{"date":"2022-05-20","current":-17.842445,"twenty":-42.833778,"median":-18.660826,"eighty":-4.945958,"marketCap":1350823076.27},{"date":"2022-05-27","current":-17.144066,"twenty":-42.833778,"median":-18.660826,"eighty":-4.959508,"marketCap":1318113089.78},{"date":"2022-06-03","current":-16.776103,"twenty":-42.833778,"median":-18.660826,"eighty":-4.959508,"marketCap":1290375423.37},{"date":"2022-06-10","current":-15.694743,"twenty":-42.833778,"median":-18.660826,"eighty":-4.959508,"marketCap":1185223120.07},{"date":"2022-06-17","current":-11.921997,"twenty":-42.833778,"median":-18.660826,"eighty":-4.959508,"marketCap":895228834.36},{"date":"2022-06-24","current":-18.998899,"twenty":-42.839081,"median":-18.754377,"eighty":-4.956121,"marketCap":1438224696.2},{"date":"2022-07-01","current":-15.041421,"twenty":-42.839081,"median":-18.773401,"eighty":-4.956121,"marketCap":1122771523.82},{"date":"2022-07-08","current":-15.627158,"twenty":-42.839081,"median":-18.773401,"eighty":-4.962896,"marketCap":1141442605.6},{"date":"2022-07-15","current":-15.199119,"twenty":-42.839081,"median":-18.773401,"eighty":-4.979834,"marketCap":1100655508.58},{"date":"2022-07-22","current":-14.742545,"twenty":-42.839081,"median":-18.773401,"eighty":-5.006936,"marketCap":1081562060.93},{"date":"2022-07-29","current":-14.493232,"twenty":-42.839081,"median":-18.773401,"eighty":-7.517387,"marketCap":1060885624.24},{"date":"2022-08-05","current":-14.616386,"twenty":-42.839081,"median":-18.773401,"eighty":-8.098598,"marketCap":1065336538.7},{"date":"2022-08-12","current":-7.475211,"twenty":-42.839081,"median":-18.773401,"eighty":-8.237263,"marketCap":1214972810.42},{"date":"2022-08-19","current":-7.189807,"twenty":-42.839081,"median":-18.773401,"eighty":-8.237263,"marketCap":1144298265.06},{"date":"2022-08-26","current":-6.840816,"twenty":-42.839081,"median":-18.773401,"eighty":-8.237263,"marketCap":1083857429.29},{"date":"2022-09-02","current":-6.154664,"twenty":-42.839081,"median":-18.773401,"eighty":-8.237263,"marketCap":978763284.51},{"date":"2022-09-09","current":-6.392747,"twenty":-42.839081,"median":-18.773401,"eighty":-8.237263,"marketCap":1017441669.68},{"date":"2022-09-16","current":-5.999393,"twenty":-42.839081,"median":-18.773401,"eighty":-8.237263,"marketCap":953114620.16},{"date":"2022-09-23","current":-4.198244,"twenty":-42.839081,"median":-18.773401,"eighty":-8.237263,"marketCap":647060247.93},{"date":"2022-09-30","current":-4.55113,"twenty":-42.839081,"median":-18.773401,"eighty":-8.237263,"marketCap":707433466.37},{"date":"2022-10-07","current":-5.236667,"twenty":-42.839081,"median":-18.773401,"eighty":-8.237263,"marketCap":811527169.81},{"date":"2022-10-14","current":-5.484535,"twenty":-42.839081,"median":-18.773401,"eighty":-8.237263,"marketCap":847288830.52},{"date":"2022-10-21","current":-5.56134,"twenty":-42.839081,"median":-18.773401,"eighty":-8.237263,"marketCap":864631259.32},{"date":"2022-10-28","current":-5.847611,"twenty":-42.839081,"median":-18.773401,"eighty":-8.237263,"marketCap":921703729.74},{"date":"2022-11-04","current":-5.856339,"twenty":-42.839081,"median":-18.773401,"eighty":-8.237263,"marketCap":920242823.16},{"date":"2022-11-11","current":13.20723,"twenty":-42.839081,"median":-18.773401,"eighty":-8.237263,"marketCap":1001700595.95},{"date":"2022-11-18","current":13.207528,"twenty":-42.839081,"median":-18.773401,"eighty":-8.237263,"marketCap":1005044997.93},{"date":"2022-11-25","current":12.303161,"twenty":-42.839081,"median":-18.773401,"eighty":-8.237263,"marketCap":939438527.61},{"date":"2022-12-02","current":12.706358,"twenty":-42.839081,"median":-18.773401,"eighty":-8.237263,"marketCap":978364263.4},{"date":"2022-12-09","current":12.653603,"twenty":-42.839081,"median":-18.773401,"eighty":-8.237263,"marketCap":979230750.34},{"date":"2022-12-16","current":11.918805,"twenty":-42.839081,"median":-18.773401,"eighty":-8.237263,"marketCap":928039037.22},{"date":"2022-12-23","current":12.344611,"twenty":-42.839081,"median":-18.773401,"eighty":-8.237263,"marketCap":962827235.26},{"date":"2022-12-30","current":11.726627,"twenty":-42.839081,"median":-18.773401,"eighty":-8.237263,"marketCap":920296470.02},{"date":"2023-01-06","current":12.133592,"twenty":-42.839081,"median":-18.624892,"eighty":-8.048443,"marketCap":945665552.96},{"date":"2023-01-13","current":12.811868,"twenty":-42.839081,"median":-18.428625,"eighty":-7.570472,"marketCap":1017866360.49},{"date":"2023-01-20","current":12.984453,"twenty":-42.839081,"median":-18.304887,"eighty":-7.32615,"marketCap":1033254554.62},{"date":"2023-01-27","current":12.125354,"twenty":-42.839081,"median":-18.158096,"eighty":-7.01265,"marketCap":966566528.44},{"date":"2023-02-03","current":12.340128,"twenty":-42.839081,"median":-18.049199,"eighty":-6.795134,"marketCap":983366945.2},{"date":"2023-02-10","current":11.450885,"twenty":-42.839081,"median":-18.018644,"eighty":-6.204351,"marketCap":897984697.78},{"date":"2023-02-17","current":10.893225,"twenty":-42.839081,"median":-17.910447,"eighty":-6.153481,"marketCap":852977359.78},{"date":"2023-02-24","current":10.226293,"twenty":-42.839081,"median":-17.842445,"eighty":-5.989651,"marketCap":792305699.51},{"date":"2023-03-03","current":10.557875,"twenty":-42.839081,"median":-17.756223,"eighty":-5.87938,"marketCap":821810905.24},{"date":"2023-03-10","current":10.015286,"twenty":-42.839081,"median":-17.564595,"eighty":-5.801877,"marketCap":784398977.18},{"date":"2023-03-17","current":9.495305,"twenty":-42.839081,"median":-17.481991,"eighty":-5.525382,"marketCap":743277601.54},{"date":"2023-03-24","current":-4.470623,"twenty":-42.839081,"median":-17.426261,"eighty":-5.333021,"marketCap":689056003.66},{"date":"2023-03-31","current":-4.664705,"twenty":-42.833778,"median":-17.266785,"eighty":-4.977808,"marketCap":726156238.59},{"date":"2023-04-06","current":-4.964999,"twenty":-42.833778,"median":-17.106519,"eighty":-4.790809,"marketCap":776870273.02},{"date":"2023-04-14","current":-5.003622,"twenty":-42.839081,"median":-16.971349,"eighty":-4.783664,"marketCap":792345256.41},{"date":"2023-04-21","current":-4.616426,"twenty":-42.844383,"median":-16.825814,"eighty":-4.712404,"marketCap":725498359.11},{"date":"2023-04-28","current":-4.242747,"twenty":-42.844383,"median":-16.736636,"eighty":-4.632477,"marketCap":670006146.81},{"date":"2023-05-05","current":-6.050412,"twenty":-42.844383,"median":-16.631541,"eighty":-4.572227,"marketCap":901203840.23},{"date":"2023-05-12","current":-5.733583,"twenty":-42.844383,"median":-16.313716,"eighty":-4.572227,"marketCap":847484701.9},{"date":"2023-05-19","current":-5.811257,"twenty":-42.844383,"median":-16.089624,"eighty":-4.572227,"marketCap":847034413.7},{"date":"2023-05-26","current":-5.582323,"twenty":-42.844383,"median":-15.932816,"eighty":-4.572227,"marketCap":810436657.01},{"date":"2023-06-02","current":-5.725407,"twenty":-42.844383,"median":-15.742193,"eighty":-4.572227,"marketCap":832101904.66},{"date":"2023-06-09","current":-6.179188,"twenty":-42.844383,"median":-15.55694,"eighty":-4.572227,"marketCap":901245305.46},{"date":"2023-06-16","current":-6.937533,"twenty":-42.844383,"median":-15.383101,"eighty":-4.572227,"marketCap":1025889466.9},{"date":"2023-06-23","current":-7.489429,"twenty":-42.849686,"median":-15.248121,"eighty":-4.561679,"marketCap":1111142679.75},{"date":"2023-06-30","current":-6.823066,"twenty":-42.849686,"median":-15.164817,"eighty":-4.561679,"marketCap":1005557275.99},{"date":"2023-07-07","current":-6.647209,"twenty":-42.849686,"median":-15.134116,"eighty":-4.561679,"marketCap":977405442.1},{"date":"2023-07-14","current":-7.104435,"twenty":-42.849686,"median":-15.093987,"eighty":-4.561679,"marketCap":1076440436.53},{"date":"2023-07-21","current":-6.993717,"twenty":-42.849686,"median":-15.020112,"eighty":-4.561679,"marketCap":1055176638.43},{"date":"2023-07-28","current":-6.938358,"twenty":-42.849686,"median":-14.963109,"eighty":-4.561679,"marketCap":1032213184.97},{"date":"2023-08-04","current":-6.825589,"twenty":-42.827429,"median":-14.906107,"eighty":-4.561679,"marketCap":1011656439.29},{"date":"2023-08-11","current":-6.883769,"twenty":-42.794213,"median":-14.742545,"eighty":-4.561679,"marketCap":1026461140.12},{"date":"2023-08-18","current":-6.106603,"twenty":-42.794213,"median":-14.649597,"eighty":-4.561679,"marketCap":899184439.25},{"date":"2023-08-25","current":-6.387531,"twenty":-42.684257,"median":-14.621095,"eighty":-4.561679,"marketCap":936475812.85},{"date":"2023-09-01","current":-6.60079,"twenty":-42.500908,"median":-14.580341,"eighty":-4.561679,"marketCap":969106274.4},{"date":"2023-09-08","current":-6.514666,"twenty":-42.500908,"median":-14.526273,"eighty":-4.561679,"marketCap":943668066.35},{"date":"2023-09-15","current":-6.45725,"twenty":-42.500908,"median":-14.485408,"eighty":-4.561679,"marketCap":932358069.33},{"date":"2023-09-22","current":-119.651677,"twenty":-42.618892,"median":-14.450088,"eighty":-4.561679,"marketCap":871678672.42},{"date":"2023-09-29","current":-112.501017,"twenty":-42.827429,"median":-14.450088,"eighty":-4.561679,"marketCap":812137517.96},{"date":"2023-10-06","current":-109.372603,"twenty":-42.827429,"median":-14.450088,"eighty":-4.561679,"marketCap":786727334.18},{"date":"2023-10-13","current":-108.519399,"twenty":-42.827429,"median":-14.450088,"eighty":-4.561679,"marketCap":782237322.22},{"date":"2023-10-20","current":-103.562691,"twenty":-42.827429,"median":-14.450088,"eighty":-4.561679,"marketCap":748323961.92},{"date":"2023-10-27","current":-105.675386,"twenty":-42.95965,"median":-14.435837,"eighty":-4.547895,"marketCap":760293006.53},{"date":"2023-11-03","current":-120.54551,"twenty":-43.150819,"median":-14.435837,"eighty":-4.547895,"marketCap":874274865.18},{"date":"2023-11-10","current":-7.776276,"twenty":-43.150819,"median":-14.38783,"eighty":-4.547895,"marketCap":945273657.2},{"date":"2023-11-17","current":-6.920128,"twenty":-42.880945,"median":-13.983711,"eighty":-4.547895,"marketCap":852988795.35},{"date":"2023-11-24","current":-6.3673,"twenty":-42.841815,"median":-13.822769,"eighty":-4.547895,"marketCap":787927360.96},{"date":"2023-12-01","current":-6.350177,"twenty":-42.592509,"median":-13.606329,"eighty":-4.547895,"marketCap":785894166.21},{"date":"2023-12-08","current":-6.276793,"twenty":-42.369364,"median":-13.399726,"eighty":-4.549512,"marketCap":768431429.5},{"date":"2023-12-15","current":-6.08844,"twenty":-42.238556,"median":-13.235496,"eighty":-4.549512,"marketCap":759632509.07},{"date":"2023-12-22","current":-5.567413,"twenty":-42.186086,"median":-13.158051,"eighty":-4.549512,"marketCap":694473074.64},{"date":"2023-12-29","current":-5.772888,"twenty":-42.199204,"median":-13.128089,"eighty":-4.547895,"marketCap":725607565.35},{"date":"2024-01-05","current":-5.946564,"twenty":-42.212321,"median":-13.037624,"eighty":-4.546277,"marketCap":739491923.29},{"date":"2024-01-12","current":-5.352152,"twenty":-41.976205,"median":-12.971666,"eighty":-4.546277,"marketCap":664917341.8},{"date":"2024-01-19","current":-4.903286,"twenty":-41.818504,"median":-12.852235,"eighty":-4.54466,"marketCap":604520176.01},{"date":"2024-01-26","current":-4.639103,"twenty":-41.556299,"median":-12.798495,"eighty":-4.546277,"marketCap":570523681.59},{"date":"2024-02-02","current":-4.334559,"twenty":-41.320183,"median":-12.751807,"eighty":-4.51195,"marketCap":533590837.49},{"date":"2024-02-09","current":-4.473988,"twenty":-41.031741,"median":-12.718828,"eighty":-4.471969,"marketCap":546486377.83},{"date":"2024-02-16","current":-4.487442,"twenty":-40.467685,"median":-12.630885,"eighty":-4.471969,"marketCap":547834869.28},{"date":"2024-02-23","current":-4.027568,"twenty":-40.179099,"median":-12.586913,"eighty":-4.386963,"marketCap":494351856.14},{"date":"2024-03-01","current":-3.858785,"twenty":-25.691288,"median":-12.448473,"eighty":-4.242747,"marketCap":473327826.18},{"date":"2024-03-08","current":-4.085052,"twenty":-25.195495,"median":-12.397276,"eighty":-4.161059,"marketCap":506613462.3},{"date":"2024-03-15","current":-4.233044,"twenty":-24.667694,"median":-12.334076,"eighty":-4.161059,"marketCap":523194254.44},{"date":"2024-03-22","current":-4.223259,"twenty":-24.488967,"median":-12.224146,"eighty":-4.118076,"marketCap":520397808.67},{"date":"2024-03-28","current":-4.976597,"twenty":-24.179168,"median":-12.152693,"eighty":-4.118076,"marketCap":545227155.97},{"date":"2024-04-05","current":-5.095642,"twenty":-23.715621,"median":-12.04039,"eighty":-4.114406,"marketCap":561422812.3},{"date":"2024-04-12","current":-5.495193,"twenty":-23.451754,"median":-11.982302,"eighty":-4.114406,"marketCap":596949646.57},{"date":"2024-04-19","current":-5.010806,"twenty":-23.196096,"median":-11.909228,"eighty":-4.114406,"marketCap":541950304.97},{"date":"2024-04-26","current":-4.712511,"twenty":-23.153903,"median":-11.795422,"eighty":-4.118076,"marketCap":512035620.78},{"date":"2024-05-03","current":-4.698827,"twenty":-22.883852,"median":-11.647018,"eighty":-4.118076,"marketCap":509893412.86},{"date":"2024-05-10","current":-19.140008,"twenty":-22.420022,"median":-11.608406,"eighty":-4.118076,"marketCap":503051638.83},{"date":"2024-05-17","current":-23.327597,"twenty":-22.244817,"median":-11.608406,"eighty":-4.118076,"marketCap":618510936.96},{"date":"2024-05-24","current":-22.133891,"twenty":-22.139768,"median":-11.608406,"eighty":-4.118076,"marketCap":584383597.79},{"date":"2024-05-31","current":-23.46877,"twenty":-22.139768,"median":-11.608406,"eighty":-4.118076,"marketCap":620769583.6},{"date":"2024-06-07","current":-22.065436,"twenty":-22.074563,"median":-11.608406,"eighty":-4.118076,"marketCap":585682453.75},{"date":"2024-06-14","current":-18.711124,"twenty":-21.834695,"median":-11.608406,"eighty":-4.118076,"marketCap":491302969.86},{"date":"2024-06-21","current":-17.707113,"twenty":-21.688129,"median":-11.607209,"eighty":-4.114406,"marketCap":462847840.76},{"date":"2024-06-28","current":-18.163482,"twenty":-21.57537,"median":-11.479685,"eighty":-4.098262,"marketCap":474319463.65},{"date":"2024-07-05","current":-18.266165,"twenty":-21.47676,"median":-11.479685,"eighty":-4.098262,"marketCap":481693575.14},{"date":"2024-07-12","current":-19.601044,"twenty":-21.005765,"median":-11.479685,"eighty":-4.098262,"marketCap":519761127.3},{"date":"2024-07-15","current":-19.156084,"twenty":-20.961672,"median":-11.479685,"eighty":-4.098262,"marketCap":510013490.5},{"date":"2024-08-02","current":-17.969525,"twenty":-20.284536,"median":-11.187293,"eighty":-4.065483,"marketCap":472746573.55},{"date":"2024-08-09","current":-17.764159,"twenty":-20.284536,"median":-11.457552,"eighty":-4.17226,"marketCap":472748342.79},{"date":"2024-08-16","current":-14.556338,"twenty":-20.284536,"median":-11.647018,"eighty":-4.223259,"marketCap":518153824.69},{"date":"2024-08-23","current":-14.82256,"twenty":-20.284536,"median":-11.795422,"eighty":-4.244086,"marketCap":533549596.8},{"date":"2024-08-30","current":-14.126947,"twenty":-20.284536,"median":-11.915612,"eighty":-4.334559,"marketCap":507102330.53},{"date":"2024-09-06","current":-13.225227,"twenty":-20.284536,"median":-11.976806,"eighty":-4.446484,"marketCap":475155147.45},{"date":"2024-09-13","current":-12.065873,"twenty":-20.284536,"median":-12.038828,"eighty":-4.527804,"marketCap":431492767.6},{"date":"2024-09-20","current":-12.679194,"twenty":-20.284536,"median":-12.098648,"eighty":-4.57428,"marketCap":457668339.27},{"date":"2024-09-27","current":-13.729956,"twenty":-20.284536,"median":-12.196663,"eighty":-4.615865,"marketCap":497313821.39},{"date":"2024-10-04","current":-13.079484,"twenty":-20.284536,"median":-12.317587,"eighty":-4.630909,"marketCap":466865118.41},{"date":"2024-10-11","current":-12.569114,"twenty":-20.284536,"median":-12.386766,"eighty":-4.657449,"marketCap":445020515.68},{"date":"2024-10-18","current":-13.309651,"twenty":-20.284536,"median":-12.417638,"eighty":-4.676934,"marketCap":467055614.51},{"date":"2024-10-25","current":-13.527884,"twenty":-20.284536,"median":-12.525184,"eighty":-4.712511,"marketCap":473534389.72},{"date":"2024-10-31","current":-12.936665,"twenty":-20.284536,"median":-12.597906,"eighty":-4.742614,"marketCap":455199257.33},{"date":"2024-11-08","current":-52.839095,"twenty":-20.409931,"median":-12.61915,"eighty":-4.870263,"marketCap":422781155.22},{"date":"2024-11-15","current":-47.717161,"twenty":-20.613798,"median":-12.714502,"eighty":-4.922401,"marketCap":374487837.49},{"date":"2024-11-22","current":-44.871643,"twenty":-21.000301,"median":-12.751807,"eighty":-4.964999,"marketCap":349163795.24},{"date":"2024-11-29","current":-40.384478,"twenty":-21.396609,"median":-12.759252,"eighty":-4.976597,"marketCap":316037621.06},{"date":"2024-12-06","current":-42.24501,"twenty":-21.57537,"median":-12.783899,"eighty":-5.00718,"marketCap":331226597.61},{"date":"2024-12-13","current":-40.078038,"twenty":-21.734568,"median":-12.842733,"eighty":-5.054971,"marketCap":311830170.97},{"date":"2024-12-20","current":-42.113678,"twenty":-21.858522,"median":-12.936665,"eighty":-5.094547,"marketCap":324334786.13},{"date":"2024-12-27","current":-46.929172,"twenty":-22.07,"median":-12.982659,"eighty":-5.198446,"marketCap":362550089.56},{"date":"2025-01-03","current":-49.205587,"twenty":-22.154919,"median":-13.032666,"eighty":-5.320372,"marketCap":374327804.33},{"date":"2025-01-10","current":-48.505151,"twenty":-22.420022,"median":-13.084488,"eighty":-5.385854,"marketCap":370404789.99},{"date":"2025-01-17","current":-45.353192,"twenty":-22.669011,"median":-13.158051,"eighty":-5.469687,"marketCap":346335164.71},{"date":"2025-01-24","current":-49.730913,"twenty":-22.889342,"median":-13.183446,"eighty":-5.525382,"marketCap":384074872.46},{"date":"2025-01-31","current":-59.712118,"twenty":-23.072569,"median":-13.224865,"eighty":-5.576219,"marketCap":461737192.74},{"date":"2025-02-07","current":-68.423783,"twenty":-23.164066,"median":-13.263244,"eighty":-5.67316,"marketCap":526631689.15},{"date":"2025-02-14","current":-73.326831,"twenty":-23.250681,"median":-13.328938,"eighty":-5.732413,"marketCap":568081912.27},{"date":"2025-02-21","current":-81.162952,"twenty":-23.44002,"median":-13.378629,"eighty":-5.794653,"marketCap":630040578.69},{"date":"2025-02-28","current":-72.276178,"twenty":-23.596448,"median":-13.439834,"eighty":-5.807815,"marketCap":557902899.06},{"date":"2025-03-07","current":-73.107945,"twenty":-23.549255,"median":-13.439745,"eighty":-5.807116,"marketCap":587302072.77},{"date":"2025-03-14","current":-68.94911,"twenty":-23.549255,"median":-13.439745,"eighty":-5.807116,"marketCap":555637691.47},{"date":"2025-03-21","current":-44.898908,"twenty":-23.549255,"median":-13.439745,"eighty":-5.807116,"marketCap":596654649.52},{"date":"2025-03-28","current":-43.44029,"twenty":-23.549255,"median":-13.439745,"eighty":-5.807116,"marketCap":574280260.15},{"date":"2025-04-04","current":-34.662063,"twenty":-23.549255,"median":-13.439745,"eighty":-5.807116,"marketCap":469898479.08},{"date":"2025-04-11","current":-36.783689,"twenty":-23.596448,"median":-13.439834,"eighty":-5.807815,"marketCap":503847263.17},{"date":"2025-04-17","current":-40.257851,"twenty":-23.596448,"median":-13.439834,"eighty":-5.807815,"marketCap":560652609.73},{"date":"2025-04-25","current":-43.04583,"twenty":-23.549255,"median":-13.439745,"eighty":-5.807116,"marketCap":598594612.24},{"date":"2025-05-01","current":-39.442754,"twenty":-23.549255,"median":-13.439745,"eighty":-5.807116,"marketCap":544717425.58}],"updateTime":1746201363162}}}